143707-72-6

143707-72-6 structure
143707-72-6 structure
  • Name: tert-Butyl N-methyl-β-alaninate
  • Chemical Name: 2-Methyl-2-propanyl N-methyl-β-alaninate
  • CAS Number: 143707-72-6
  • Molecular Formula: C8H17NO2
  • Molecular Weight: 159.226
  • Create Date: 2018-02-16 08:00:00
  • Modify Date: 2024-01-10 17:12:35

Name 2-Methyl-2-propanyl N-methyl-β-alaninate
Synonyms NITROUS ACID,t-BUTYL ESTER
tert-butyl 3-(methylamino)propanoate
tert.-butylnitrite
tert-butyl 3-(methylamino)propionate
tert-bytylnitrite
(CH3)3CONO
tert-butyl N-methyl-3-amino-propanoate
β-Alanine, N-methyl-, 1,1-dimethylethyl ester
tertiary-butyl nitrite
tert-Butyl N-methyl-β-alaninate
t-butyl nitrite
1,1-Dimethylethyl nitrite
tert-butyl 3-(N-methylamino)propionate
Nitrous Acid tert-Butyl Ester
2-Methyl-2-propanyl N-methyl-β-alaninate
Density 0.9±0.1 g/cm3
Boiling Point 203.7±23.0 °C at 760 mmHg
Molecular Formula C8H17NO2
Molecular Weight 159.226
Flash Point 77.0±22.6 °C
Exact Mass 159.125931
PSA 38.33000
LogP 1.07
Vapour Pressure 0.3±0.4 mmHg at 25°C
Index of Refraction 1.428

~93%

143707-72-6 structure

143707-72-6

Literature: Universite De Nantes; Chu Nantes; Institut National De La Sante Et De La Recherche Medicale (Inserm); Centre National De La Recherche Scientifique (CNRS) Patent: US2010/311695 A1, 2010 ; Location in patent: Page/Page column 6; 8 ;

~81%

143707-72-6 structure

143707-72-6

Literature: Howard, Nigel I.; Bugg, Timothy D. H. Bioorganic and Medicinal Chemistry, 2003 , vol. 11, # 14 p. 3083 - 3099

~%

143707-72-6 structure

143707-72-6

Literature: Pfizer Inc. Patent: US2012/165343 A1, 2012 ;

~%

143707-72-6 structure

143707-72-6

Literature: Ogawa, Tadashi; Araki, Mamoru; Miyamae, Tetsuhisa; Okayama, Toru; Hagiwara, Masaki; Sakurada, Shinobu; Morikawa, Tadanori Chemical and Pharmaceutical Bulletin, 2003 , vol. 51, # 7 p. 759 - 771

~%

143707-72-6 structure

143707-72-6

Literature: Ogawa, Tadashi; Araki, Mamoru; Miyamae, Tetsuhisa; Okayama, Toru; Hagiwara, Masaki; Sakurada, Shinobu; Morikawa, Tadanori Chemical and Pharmaceutical Bulletin, 2003 , vol. 51, # 7 p. 759 - 771